Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M131Revenue $M16.3Net Margin (%)-126.7Z-Score1.4
Enterprise Value $M128EPS $-0.2Operating Margin %-202.4F-Score1
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-138.2Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio3.9Cash flow > EarningsN
Price/Sales10.75-y EBITDA Growth Rate %104Current Ratio5.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-17.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-30.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M75.0ROI % (ttm)-45.5Gross Margin Increase y-yN

Gurus Latest Trades with NEPT

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NEPT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

NEPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montgomery, Adrian TaylorDirector 2014-12-03Buy11,000$2.21-20.81view
Moretz, John MorrisDirector 2014-11-25Buy31,382$2.09-16.27view
Moretz, John MorrisDirector 2014-11-24Buy68,188$2.15-18.6view
Lemieux, PierreDirector or Senior Officer of Insider or Subsidiar 2014-11-12Buy5,000$2.19-20.09view
Godin, AndréSenior Officer 2014-11-12Buy3,000$2.15-18.6view
Ripplinger, JohnSenior Officer 2014-11-11Buy3,550$2.12-17.45view
Turcotte, MarioSenior Officer 2014-11-11Buy6,870$2.14-18.22view
Godin, AndréSenior Officer 2014-11-11Buy8,000$2.12-17.45view
Fitzgibbon, PierreDirector 2014-11-10Buy37,500$2.09-16.27view
Huart, BenoîtDirector 2014-11-10Buy7,000$2.03-13.79view

Press Releases about NEPT :

    Quarterly/Annual Reports about NEPT:

      News about NEPT:

      Articles On GuruFocus.com
      What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 

      More From Other Websites
      Acasti Announces Third Quarter Results Jan 13 2015
      Neptune Announces Third Quarter Results Jan 13 2015
      NeuroBioPharm to be Privatized by Neptune - Enters Into Arrangement Agreement With Neptune and... Jan 13 2015
      5 Earnings Short-Squeeze Plays: Neptune Technologies and More Jan 13 2015
      Neptune to Present at OneMedForum Jan 08 2015
      Neptune to Hold Conference Call to Discuss Third Quarter Results Jan 06 2015
      Neptune Completes Plant Ramp-Up Dec 03 2014
      Jim Hamilton Appointed President & CEO of Neptune Dec 03 2014
      Jim Hamilton Appointed President & CEO of Neptune Nov 21 2014
      Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements Nov 11 2014
      Neptune Completes Plant Ramp-Up Nov 05 2014
      Neptune Receives TSX Approval For Normal Course Issuer Bid Oct 30 2014
      Activist George Haywood Reveals New Biotech Target Oct 28 2014
      Neptune and BlueOcean Sign Licensing Agreement Oct 20 2014
      Neptune Announces Normal Course Issuer Bid Oct 16 2014
      Neptune Announces Second Quarter Results – Shipments of NKO® Underway Oct 16 2014
      Neptune to Hold Conference Call to Discuss Second Quarter Results Oct 16 2014
      Short-term bulls diving for Neptune Sep 16 2014
      Why Neptune Technologies (NEPT) Could Be Positioned for a Slump Jul 30 2014
      Has Enzymotec Been Over-Punished? Jun 09 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial